213 related articles for article (PubMed ID: 28731140)
1. Integrated analysis of genome‑wide gene expression and DNA methylation microarray of diffuse large B‑cell lymphoma with TET mutations.
Liu P; Jiang W; Zhao J; Zhang H
Mol Med Rep; 2017 Oct; 16(4):3777-3782. PubMed ID: 28731140
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Asmar F; Punj V; Christensen J; Pedersen MT; Pedersen A; Nielsen AB; Hother C; Ralfkiaer U; Brown P; Ralfkiaer E; Helin K; Grønbæk K
Haematologica; 2013 Dec; 98(12):1912-20. PubMed ID: 23831920
[TBL] [Abstract][Full Text] [Related]
3. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
5. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
6. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.
Luo X; Shi F; Qiu H; Tong Y; Gao X
Neoplasma; 2017; 64(6):824-833. PubMed ID: 28895406
[TBL] [Abstract][Full Text] [Related]
8. [Identify the Molecular Target of Diffuse Large B Cell Lymphoma by Bioinformatics Analysis].
Zhou Y; He S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1585-1591. PubMed ID: 33067958
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles.
Wei S; Yun X; Ruan X; Wei X; Zheng X; Gao M
Oncol Lett; 2019 Dec; 18(6):6670-6678. PubMed ID: 31814850
[TBL] [Abstract][Full Text] [Related]
11. Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles.
Liu D; Liu P; Cao L; Zhang Q; Chen Y
Oncol Lett; 2017 Oct; 14(4):3975-3980. PubMed ID: 28943905
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed and methylated genes associated with rheumatoid arthritis based on network.
Zhang D; Li Z; Zhang R; Yang X; Zhang D; Li Q; Wang C; Yang X; Xiong Y
Autoimmunity; 2020 Sep; 53(6):303-313. PubMed ID: 32650679
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
14. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Sun C; Cheng X; Wang C; Wang X; Xia B; Zhang Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393234
[TBL] [Abstract][Full Text] [Related]
15. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Zhang Y; Fang L; Zang Y; Xu Z
Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
Zhou W; Ma CX; Xing YZ; Yan ZY
Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
[TBL] [Abstract][Full Text] [Related]
17. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
18. Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome.
Feng Y; Liang H; Han M; Luo X; Zhu Y; Liu B
Hematology; 2023 Dec; 28(1):2220222. PubMed ID: 37288803
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
20. Identification of DNA methylation-regulated differentially expressed genes in RA by integrated analysis of DNA methylation and RNA-Seq data.
Zhang R; Chang C; Jin Y; Xu L; Jiang P; Wei K; Xu L; Guo S; Sun S; He D
J Transl Med; 2022 Oct; 20(1):481. PubMed ID: 36273177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
